Intriguingly, a low level of miRNA‐125a and miRNA-125b in M2-sEVs inhibit proliferation and stem cell characteristics of HCC cells by targeting CD90, a stem cell marker of HCC (Wang et al., 2019a). Here, THY1 is linked to hepatocellular carcinoma.